Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery

We evaluated the in-hospital and 1-year outcomes in 119 consecutive patients who underwent minimally invasive direct coronary artery bypass grafting (MID-CAB) with 441 consecutive patients undergoing coronary stenting in isolated proximal or mid-left anterior descending lesions. MIDCAB and coronary artery stenting have very similar in-hospital and 1-year mortality and myocardial infarction rates; MIDCAB requires longer hospitalization, but the current stent designs have higher 1-year target vessel revascularization and major adverse cardiac event, rates than MIDCAB.